The American Society of Clinical Oncology (ASCO) recently released an update to its 2013 guidelines for fertility preservation in patients with cancer. Study members conducted a review of 61 relevant publications and determined that none of these publications prompted a significant change in the 2013 recommendations. ASCO recommends the following and advises healthcare providers to discuss the possibility of infertility with patients as soon as possible.
ASCO Reccomendations Health care providers should initiate the discussion on the possibility of infertility with patients with cancer treated during their reproductive years or with parents/guardians of children as early as possible. Providers should be prepared to discuss fertility preservation options and/or to refer all potential patients to appropriate reproductive specialists. Although patients may be focused initially on their cancer diagnosis, providers should advise patients regarding potential threats to fertility as early as possible in the treatment process so as to allow for the widest array of options for fertility preservation. The discussion should be documented. Sperm, oocyte, and embryo cryopreservation are considered standard practice and are widely available. There is conflicting evidence to recommend gonadotrophin-releasing hormone agonists (GnRHa) and other means of ovarian suppression for fertility preservation. The Panel recognizes that, when proven fertility preservation methods are not feasible, and in the setting of young women with breast cancer, GnRHa may be offered to patients in the hope of reducing the likelihood of chemotherapy-induced ovarian insufficiency. GnRHa should not be used in place of proven fertility preservation methods. The panel notes that the field of ovarian tissue cryopreservation is advancing quickly and may evolve to become standard therapy in the future. Additional information is available at www.asco.org/survivorship-guidelines.
Oncofertility Gloabl Partners colleagues in India recently launched the first oncofertility focused journal. The Onco Fertility Journal, a publication of Fertility Preservation Society (India), is a peer-reviewed print and online semi-annual journal that aims to address issues on fertility and...
Congratulations to our colleagues in Tunisia who recently published in Future Oncology. The paper "Perurethral transvesical route for oocytes retrieval: an old technique for a new indication in oncofertility" aimed to evaluate the safety and efficiency of the peruretheral transvesical oocyte...
Below are 20 new and notable publications from the field of oncofertility over the past six months. Congratulations to all of our colleagues on these publications.
Congratulations to our colleagues in Australia who recently published two new review papers in the Journal of Psycho-Oncology. Read the abstracts below and click the links to read the full text.
Last month, author Chloé McFeters released six coloring book journals for adults, including C is for Courage, a coloring book journal for those living with cancer. The book’s journal prompts invite the reader to write about the practical and emotional aspects of the journey with cancer, while the...
Members of the Global Partners Network recently published a commentary in the Biology of Reproduction. Below is more information from first author Saskia de Roo, who spent last year studying at the Consortium.
Let me first introduce myself, I am Saskia de Roo, and I graduated last January from...
Dr. Francesca Duncan and her colleagues recently published in the Proceedings of the National Academy of Sciences (PNAS).
This paper "mTORC1/2 Inhibition Preserves Ovarian Function and Fertility during Genotoxic Chemotherapy" is significant for the following reasons: "A major unresolved issue for...
Drs. Teresa Woodruff and Shuo Xiao recently published in Toxicological Sciences, which is one of the top journals in toxicology field. This paper examined doxorubicin and its effect on follicle function and oocyte health. Here is more information about the paper from its author Dr. Shuo Xiao:
In January, 2017, Jessica R. Gorman from Oregon State University and colleagues published a study in the Journal of Cancer Survivorship comparing adoption considerations between female young adult cancer survivors and women of the same age in the general population. This study found that among...
The fifth book in the oncofertility series: Pediatric and Adolescent Oncofertility Best Practices and Emerging Technologies, is now available for purchase! The first book of its kind presenting a comprehensive discussion of pediatric and adolescent oncofertility. Congratulations to all of our...
Drs. Miyuki Harada and Yutaka Osuga, both colleagues in Japan, recently published a perspectives article in Future Oncology: Where are oncofertility and fertility preservation treatments heading in 2016?
Below is an excerpt from the paper which assesses the state of oncofertility and the progress...
Dr. Monica Laronda and colleagues recently published a paper in the Journal of Assisted Reproduction entitled "Good manufacturing practice requirements for the production of tissue vitrification and warming and recovery kits for clinical research" . The main objective of this study was to...
Oncofertility colleagues, Drs. Richard Anderson and Melanie Davies from the UK recently published an editorial in The BMJ encouraging specialists across the UK to standardize fertility preservation interventions since awareness about fertility preservation remains relatively low. Despite national...
Congratulations to our colleagues in Portugal who recently published a paper in Human Reproduction. The paper Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis appeared in the September online issue of the journal. To read...
A new study published in the Journal of Clinical Oncology reports endocrine abnormalities in aging childhood cancer survivors. The study, a part of the Childhood Cancer Survivor Study, found "cumulative incidence and prevalence of endocrine abnormalities increased across the lifespan of survivors...
The contents of the Oncofertility Consortium Blog are for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
965 Wilson Road, Room A626B
East Lansing, MI 48824-1316
Phone: 1 (517) 884 8848
Email: oncofert@msu.edu
NOTICE:
Ownership of this website has been transferred from Northwestern University to Michigan State University. Please note that some site information may be inaccurate while adjustments to reflect this organizational change are made.